Annual report pursuant to Section 13 and 15(d)

Schedule I - Condensed Statements of Cash Flow (Details)

v3.22.4
Schedule I - Condensed Statements of Cash Flow (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 71,978 $ 59,427 $ 30,639
Adjustments to reconcile net income to net cash provided by operating activities:      
Deferred income taxes 22,300 4,848 (4,747)
Depreciation and amortization 101,752 97,194 74,396
Foreign currency (gain) loss 227 (1,320) 6,754
Share-based compensation 12,161 5,804 1,891
Other operating activities, net 775 677 115
Changes in assets and liabilities:      
Decrease (increase) in other current assets 1,476 (5,421) (7,864)
(Decrease) increase in other current liabilities 6,884 7,867 46,303
Net cash provided by (used in) operating activities 209,256 159,191 173,842
Cash flows from investing activities:      
Net cash provided by (used in) investing activities (175,488) (171,777) (407,551)
Cash flows from financing activities:      
Receipt of long term debt, net 70,896 484,089 570,207
Issuance of shares in Merger Transaction 0 0 57,997
Payment of Merger Transaction issuance costs 0 (4,773) 0
Issuance of redeemable preferred stock, net 0 0 96,880
Common stock repurchased (40,042) 0 0
Dividends paid on common stock (10,893) 0 0
Dividends paid on redeemable preferred stock (5,750) (5,892) 0
Buyback of long-term debt 0 0 (1,995)
Proceeds from issuance of rights, net 0 0 11,332
Net cash provided by (used in) financing activities 10,555 (26,384) 491,048
Effect of exchange rate on cash and cash equivalents and restricted cash (97) (1,464) 2,875
Cash and cash equivalents and restricted cash, beginning of year 272,543 312,977 52,763
Cash and cash equivalents and restricted cash, end of year 316,769 272,543 312,977
Reconciliation of cash and cash equivalents and restricted cash      
Cash and cash equivalents, beginning of year 252,141 293,666 32,117
Restricted cash with respect to bonds, beginning of year 0 2,782 6,223
Cash and cash equivalents and restricted cash, beginning of year 272,543 312,977 52,763
Supplementary cash flow information:      
Cash received for interest 1,964 428 1,323
Cash paid for interest 57,653 51,495 40,026
Cash paid for taxes 6,747 14,912 1,163
Supplementary noncash activities:      
Prepaid insurance premiums financed through notes payable 6,668 8,210 7,224
Parent Company      
Cash flows from operating activities:      
Net income 71,747 59,198 13,710
Adjustments to reconcile net income to net cash provided by operating activities:      
Equity income from subsidiaries (74,024) (71,955) (23,863)
Deferred income taxes 164 519 (130)
Amortization debt discount and premium 759 152 (331)
Depreciation and amortization 0 0 8
Foreign currency (gain) loss (1,693) (4,656) 4,703
Share-based compensation 955 868 1,891
Fair value adjustment of financial liabilities (887) 5,021 107
Other operating activities, net 0 0 (38)
Changes in assets and liabilities:      
Decrease (increase) in other current assets 6,752 (3,713) 942
(Decrease) increase in other current liabilities (11,542) 1,586 490
Net cash provided by (used in) operating activities (4,711) (8,726) (2,511)
Cash flows from investing activities:      
Loans to investees 0 (450,000) (68,939)
Repayments of loans to subsidiaries and other investees 40,000 0 109,946
Distribution from subsidiary 28,109 0 0
Investment in subsidiary 0 0 (107,299)
Net cash provided by (used in) investing activities 68,109 (450,000) (66,292)
Cash flows from financing activities:      
Receipt of long term debt, net 0 442,737 0
Issuance of shares in Merger Transaction 0 0 60,318
Payment of Merger Transaction issuance costs 0 (4,773) 0
Issuance of redeemable preferred stock, net 0 0 96,880
Common stock repurchased (40,042)    
Dividends paid on common stock (10,893) 0 0
Dividends paid on redeemable preferred stock (5,750) (5,892) 0
Repayment of long-term debt (1,500) (2,017) (10,953)
Buyback of long-term debt 0 0 (1,995)
Proceeds from issuance of rights, net 0 0 11,332
Net cash provided by (used in) financing activities (58,185) 430,055 155,582
Net increase (decrease) in cash and cash equivalents and restricted cash 5,213 (28,671) 86,779
Effect of exchange rate on cash and cash equivalents and restricted cash 0 0 2,875
Cash and cash equivalents and restricted cash, beginning of year 88,508 117,179 27,525
Cash and cash equivalents and restricted cash, end of year 93,721 88,508 117,179
Reconciliation of cash and cash equivalents and restricted cash      
Cash and cash equivalents, beginning of year 88,508 117,179 21,302
Restricted cash with respect to bonds, beginning of year 0 0 6,223
Cash and cash equivalents and restricted cash, beginning of year 88,508 117,179 27,525
Supplementary cash flow information:      
Cash received for interest 26,028 1,404 2,340
Cash paid for interest 24,610 14 3,840
Cash paid for taxes 735 6,175 305
Supplementary noncash activities:      
Prepaid insurance premiums financed through notes payable 1,145 1,765 2,190
Issuance of shares 0 3,000 0
Ares Put Option $ 0 $ 0 $ 9,201